Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

N-acetylcysteine reduces … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury.

Artikel i vetenskaplig tidskrift
Författare Xiaoyang Wang
Pernilla Svedin
Chunxia Nie
Risto Lapatto
Changlian Zhu
Malin Gustavsson
Mats Sandberg
Jan-Olof Karlsson
Roberto Romero
Henrik Hagberg
Carina Mallard
Publicerad i Annals of neurology
Volym 61
Nummer/häfte 3
Sidor 263-71
ISSN 0364-5134
Publiceringsår 2007
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för fysiologi
Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering
Institutionen för biomedicin, avdelningen för medicinsk kemi och cellbiologi
Institutionen för kliniska vetenskaper
Sidor 263-71
Språk en
Länkar dx.doi.org/10.1002/ana.21066
Ämnesord Animals, Animals, Newborn, Apoptosis, drug effects, Calpain, drug effects, Caspases, drug effects, Cystine, analogs & derivatives, pharmacology, Enzyme Activation, drug effects, Glutathione, drug effects, Hypoxia-Ischemia, Brain, chemically induced, prevention & control, Isoprostanes, metabolism, Lipopolysaccharides, toxicity, Membrane Proteins, drug effects, Neuroprotective Agents, pharmacology, Oxidation-Reduction, drug effects, Rats, Rats, Wistar, Thioredoxin, drug effects, Tyrosine, analogs & derivatives, drug effects
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

OBJECTIVE: Maternal inflammation/infection alone or in combination with birth asphyxia increases the risk for perinatal brain injury. Free radicals are implicated as major mediators of inflammation and hypoxia-ischemia (HI)-induced perinatal brain injury. This study evaluated the neuroprotective efficacy of a scavenging agent, N-acetylcysteine (NAC), in a clinically relevant model. METHODS: Lipopolysaccharide (LPS)-sensitized HI brain injury was induced in 8-day-old neonatal rats. NAC was administered in multiple doses, and brain injury was evaluated at 7 days after HI. RESULTS: NAC (200mg/kg) provided marked neuroprotection with up to 78% reduction of brain injury in the pre+post-HI treatment group and 41% in the early (0 hour) post-HI treatment group, which was much more pronounced protection than another free radical scavenger, melatonin. Protection by NAC was associated with the following factors: (1) reduced isoprostane activation and nitrotyrosine formation; (2) increased levels of the antioxidants glutathione, thioredoxin-2, and (3) inhibition of caspase-3, calpain, and caspase-1 activation. INTERPRETATION: NAC provides substantial neuroprotection against brain injury in a model that combines infection/inflammation and HI. Protection by NAC was associated with improvement of the redox state and inhibition of apoptosis, suggesting that these events play critical roles in the development of lipopolysaccharide-sensitized HI brain injury.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?